Advion Expands Statin-Class Non-Proprietary LC/MS/MS Method Offering

Dedicated to Science, Dedicated to You

June 19, 2007– The statin class of drugs has been developed to lower cholesterol in people with risk of cardiovascular disease. Statins inhibit the enzyme HMG-CoA reductase which stimulates the LDL receptors thereby decreasing blood cholesterol levels. Advion recognizes the importance of validated LC/MS statin methods to the pharmaceutical industry in the development of cardiovascular drugs. While statins are well studied and understood, ongoing comparison studies and drug-drug research is needed on new chemical entities that are complimentary.

Advion’s offering of statin non-proprietary methods are all validated in human plasma with stable-label internal standards and include:

Atorvastatin, o-hydroxyatorvastatin, p-hydroxyatorvastatin
Fenofibric acid
Lovastatin, lovastatin acid
Simvastatin, simvastatin acid

A full list of Advion’s validated non-proprietery methods to support drug-drug interactions or comparison studies is available on its website.